These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9622055)

  • 1. The Cbl family of signal transduction molecules.
    Smit L; Borst J
    Crit Rev Oncog; 1997; 8(4):359-79. PubMed ID: 9622055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD; Langdon WY
    Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation.
    Bustelo XR; Crespo P; López-Barahona M; Gutkind JS; Barbacid M
    Oncogene; 1997 Nov; 15(21):2511-20. PubMed ID: 9399639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction.
    Miyake S; Lupher ML; Andoniou CE; Lill NL; Ota S; Douillard P; Rao N; Band H
    Crit Rev Oncog; 1997; 8(2-3):189-218. PubMed ID: 9570294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
    Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
    Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The c-Cbl oncoprotein.
    Lupher ML; Andoniou CE; Bonita D; Miyake S; Band H
    Int J Biochem Cell Biol; 1998 Apr; 30(4):439-44. PubMed ID: 9675877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.
    Thien CB; Langdon WY
    Oncogene; 1997 May; 14(18):2239-49. PubMed ID: 9174060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif.
    Blake TJ; Shapiro M; Morse HC; Langdon WY
    Oncogene; 1991 Apr; 6(4):653-7. PubMed ID: 2030914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development.
    Meisner H; Daga A; Buxton J; Fernández B; Chawla A; Banerjee U; Czech MP
    Mol Cell Biol; 1997 Apr; 17(4):2217-25. PubMed ID: 9121472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl.
    Thien CB; Langdon WY
    Oncogene; 1997 Dec; 15(24):2909-19. PubMed ID: 9416834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation.
    Galisteo ML; Dikic I; Batzer AG; Langdon WY; Schlessinger J
    J Biol Chem; 1995 Sep; 270(35):20242-5. PubMed ID: 7657591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-Cbl, the Drosophila homologue of the c-Cbl proto-oncogene, interacts with the Drosophila EGF receptor in vivo, despite lacking C-terminal adaptor binding sites.
    Hime GR; Dhungat MP; Ng A; Bowtell DD
    Oncogene; 1997 Jun; 14(22):2709-19. PubMed ID: 9178769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirements of multiple domains of SLI-1, a Caenorhabditis elegans homologue of c-Cbl, and an inhibitory tyrosine in LET-23 in regulating vulval differentiation.
    Yoon CH; Chang C; Hopper NA; Lesa GM; Sternberg PW
    Mol Biol Cell; 2000 Nov; 11(11):4019-31. PubMed ID: 11071924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.
    Ribon V; Hubbell S; Herrera R; Saltiel AR
    Mol Cell Biol; 1996 Jan; 16(1):45-52. PubMed ID: 8524328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The signal transduction through Grb2/Ash in hematopoietic cells.
    Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
    Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase.
    Ota S; Hazeki K; Rao N; Lupher ML; Andoniou CE; Druker B; Band H
    J Biol Chem; 2000 Jan; 275(1):414-22. PubMed ID: 10617633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation.
    Sawasdikosol S; Chang JH; Pratt JC; Wolf G; Shoelson SE; Burakoff SJ
    J Immunol; 1996 Jul; 157(1):110-6. PubMed ID: 8683103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
    Sattler M; Pride YB; Quinnan LR; Verma S; Malouf NA; Husson H; Salgia R; Lipkowitz S; Griffin JD
    Oncogene; 2002 Feb; 21(9):1423-33. PubMed ID: 11857085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncogenic 70Z Cbl mutation blocks the phosphotyrosine binding domain-dependent negative regulation of ZAP-70 by c-Cbl in Jurkat T cells.
    van Leeuwen JE; Paik PK; Samelson LE
    Mol Cell Biol; 1999 Oct; 19(10):6652-64. PubMed ID: 10490604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cbl oncogene: a novel substrate of protein tyrosine kinases.
    Langdon WY
    Aust N Z J Med; 1995 Dec; 25(6):859-64. PubMed ID: 8770364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.